NLG
New Legacy Group Portfolio holdings
AUM
$36.6M
This Quarter Return
-28.05%
1 Year Return
+36.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$49.3M
AUM Growth
+$49.3M
(-82%)
Cap. Flow
-$99.1M
Cap. Flow
% of AUM
-200.93%
Top 10 Holdings %
Top 10 Hldgs %
83.11%
Holding
29
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$764K |
Top Sells
| 1 |
Rivian
RIVN
|
$99.6M |
| 2 |
iShares Russell 2000 Growth ETF
IWO
|
$221K |
Sector Composition
| 1 | Consumer Discretionary | 35.71% |
| 2 | Communication Services | 9.99% |
| 3 | Technology | 5.05% |
| 4 | Healthcare | 0.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares US Consumer Discretionary ETF
IYC
$1.72B
| $238K | 0.48% |
4,200
| – | – |
|
27
SPDR S&P Biotech ETF
XBI
$5.07B
| $208K | 0.42% |
2,805
| – | – |
|
|
PHAS
28
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $144K | 0.29% |
240,575
| – | – |
|
|
29
iShares Russell 2000 Growth ETF
IWO
$12.4B
| – | – |
-862
| Closed | -$221K |
|